TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31, 2023, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.24-0274.

The 2023 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company’s website: www.transgene.fr, in the “Investors/Financial information” section and on the AMF website: www.amf-france.org.

It includes:

  • the 2023 annual financial report;
  • the report of the Board of Directors on corporate governance;
  • the statutory auditor’s reports;
  • information on the share buyback program;
  • information related on the auditor’s fees.

The universal registration document also includes information on the Company’s environmental and social responsibility.

Contacts

Transgene:
Lucie Larguier
Chief Financial Officer
+33 (0)3 88 27 91 04
investorrelations@transgene.fr		 

Attachment

  • 20240411_Transgene_mise_a_disposition_URD_2023_EN